REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol)

Authors:
  • ADA. Dessì
    A. Dessì
  • STS. Tolu
    S. Tolu
  • MPM. Puzzoni
    M. Puzzoni
  • ACA. Cubeddu
    A. Cubeddu
  • ELE. Lai
    E. Lai
  • RMR. Mascia
    R. Mascia
  • PZP. Ziranu
    P. Ziranu
  • LOL. Orgiano
    L. Orgiano
  • VPV. Pusceddu
    V. Pusceddu
  • GAG. Astara
    G. Astara

Abstract
Background: The introduction of regorafenib represented a significant step forward for metastatic colorectal cancer patients. Available data seem to indicate that a not negligible proportion of patients does not derive any benefit from this treatment and is thus exposed to unnecessary toxicity.